From professional translators, enterprises, web pages and freely available translation repositories.
transcriptase inhibitors - nnrti-d) (nt delavirdiin, nevirapiin)
transcriptase inhibitors (nnrtis) (e.g., delavirdine, nevirapine)*
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
see kuulub hiv vastaste ravimite rühma nimetusega mittenukleosiidsed pöördtranskriptaasi inhibiitorid (ingl non-nucleoside reverse transcriptase inhibitors, nnrti).
it belongs to a group of hiv medicines called non-nucleoside reverse transcriptase inhibitors (nnrtis).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
hiv-1 resistentsus lamivudiini suhtes on seotud m184v aminohappe muutuse tekkega viiruse pöördtranskriptaasi (reverse transcriptase, rt) toimekoha lähedal.
hiv-1 resistance to lamivudine involves the development of a m184v amino acid change close to the active site of the viral reverse transcriptase (rt).
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
sustiva' t soovitatav annus on 600 mg, manustatuna 1 kord ööpäevas kombinatsioonis nukleosiidanaloogide pöördtranskriptaasi inhibiitoritega (nucleoside analogue reverse transcriptase inhibitor, nrti), koos pi- ga või ilma (vt lõik 4. 5).
adults and adolescents over 40 kg: the recommended dosage of sustiva in combination with nucleoside analogue reverse transcriptase inhibitors (nrtis) with or without a pi (see section 4.5) is 600 mg orally, once daily.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.